Navigation Links
Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology

ES versus ReoproR-BMS in the prevention of the cumulative incidence of death, MI, and TVR in acute myocardial infarction patients. The results from MULTI-STRATEGY are anticipated to be presented at a prominent scientific symposium in early 2008.


"These papers highlight the ongoing interest in evaluating new investigational uses of AGGRASTATR in the treatment of high risk cardiovascular disease patients," stated Medicure's President and CEO, Albert D. Friesen, PhD. "We believe AGGRASTATR has significant untapped potential, and look forward to the presentation of new data from studies such as MULTI-STRATEGY in the coming year."


Medicure acquired the exclusive U.S. rights to AGGRASTATR, in August 2006.


Important Information About AGGRASTATR AGGRASTATR was approved by the Food and Drug Administration on May 14, 1998.

AGGRASTATR, in combination with heparin, is indicated for the treatment of acute coronary syndrome, including patients who are to be medically managed and those undergoing percutaneous transluminal coronary angioplasty (PTCA) or atherectomy. In this setting AGGRASTATR has been shown to decrease the rate of a combined endpoint of death, new myocardial infarction or refractory ischemia/repeat cardiac procedure. AGGRASTATR has been studied in a setting that included aspirin and heparin.

AGGRASTATR is contraindicated in patients with known hypersensitivity to any component of the product; active internal bleeding or a history of bleeding diathesis within the previous 30 days; or a history of intracranial hemorrhage, intracranial neoplasm, arteriovenous malformation, or aneurysm. Other contraindications to AGGRASTATR include: a history of thrombocytopenia following prior exposure to AGGRASTATR; history of stroke within 30 days or any history of hemorrhagic stroke; major surgical procedure or severe physical trauma within the previous month; history, symptoms, or findings suggestive of aortic dissection. AGG
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
2. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Protox Announces Positive Clinical Data from Prostate Cancer Study
4. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
5. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
6. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
7. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
8. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
9. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
10. Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis
11. Alkermes Announces Positive Results from Phase 1/2 Clinical Study of ALKS 29
Post Your Comments:
(Date:5/22/2013)... , May 22, 2013  Rosetta Genomics Ltd. ... provider of microRNA-based molecular diagnostics, announces that ... Officer of Rosetta Genomics, will deliver a corporate update ... June 3-6, 2013 in New York City.  Mr. Berlin,s ... at 2:00 p.m. Eastern time. The ...
(Date:5/22/2013)... 2013  BD (Becton, Dickinson and Company) (NYSE: ... announced today the publication of its 2012 Sustainability ... it continues to focus on the Company,s shared value ... principles of shared value — creating value for shareholders ... — are fundamental to our strategy," said ...
(Date:5/22/2013)... /PRNewswire-iReach/ -- MarketReportsOnline.com announces addition of new market ... 2013 Edition Material and Clinical Trial Requirements of ... Guidebook of Registration Application for Imported Traditional Chinese ... database. The traditional medicines in Orient, ... by occidental as mysterious medicines. Until today not ...
Breaking Medicine Technology:Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 2Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 3BD Issues 2012 Sustainability Report 2BD Issues 2012 Sustainability Report 3China Pharmaceutical Market Guidebook Series (4) 2013 Report 2China Pharmaceutical Market Guidebook Series (4) 2013 Report 3China Pharmaceutical Market Guidebook Series (4) 2013 Report 4China Pharmaceutical Market Guidebook Series (4) 2013 Report 5
... ClearChoice Holdings, LLC ("ClearChoice"), a market leading developer ... consumers with same-day dental implant care, today ... , the leading consumer-focused private equity firm. ... strategies and accelerate its expansion plan to double the ...
... NEW YORK, Oct. 6, 2011 ... new market research report is ... Diabetes Care Devices: ... Opportunity Assessment, Competitive Landscape and ...
Cached Medicine Technology:ClearChoice Receives Investment From Leading Consumer Private Equity Firm Catterton Partners 2ClearChoice Receives Investment From Leading Consumer Private Equity Firm Catterton Partners 3ClearChoice Receives Investment From Leading Consumer Private Equity Firm Catterton Partners 4Diabetes Care Devices: Emerging Countries (China, India, Brazil) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016 2Diabetes Care Devices: Emerging Countries (China, India, Brazil) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016 3Diabetes Care Devices: Emerging Countries (China, India, Brazil) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016 4Diabetes Care Devices: Emerging Countries (China, India, Brazil) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016 5Diabetes Care Devices: Emerging Countries (China, India, Brazil) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016 6Diabetes Care Devices: Emerging Countries (China, India, Brazil) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016 7Diabetes Care Devices: Emerging Countries (China, India, Brazil) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016 8
(Date:5/22/2013)... new guidelines the first in more than 35 ... for surgical patients. The recommendations, based on a lengthy ... (JHH), can potentially save the medical center more than ... , A report on the research that led up ... Anesthesiology , suggests millions of dollars a year ...
(Date:5/22/2013)... NY (PRWEB) May 22, 2013 ... now have access to Adapt Courseware’s new ... in an adaptive framework that responds based on ... Courseware , the provider of comprehensive adaptive online ... is continuing to develop introductory level general education ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 The health care ... In some states, up to twenty-seven percent of all adults ... bankruptcies of private citizens in the U.S. are related to ... affects prescription drugs, meaning that many patients cannot afford to ... get them filled at all. That's why MedicationDiscountCard.com is ...
(Date:5/22/2013)... 2013 NBA Draft tickets go on ... 22, 2013. , The 2013 NBA Draft will be held at ... of the Brooklyn Nets. The Barclays Center has already become ... artists such as Paul McCartney and Beyonce have already booked sold ... Soleil will also perform at this state-of-the-art venue. Disney on ...
(Date:5/22/2013)... Brook, New York (PRWEB) May 22, 2013 ... that specializes in combining treatments for optimal results, is ... thin skin on the neck. The practice has ... seen dramatic results. , “Basically, this approach is for ... lift,” says Westchester dermatologist Dr. Michelle Abadir ...
Breaking Medicine News(10 mins):Health News:Johns Hopkins rewrites obsolete blood-ordering rules 2Health News:Johns Hopkins rewrites obsolete blood-ordering rules 3Health News:Adapt Courseware Releases Introduction to Sociology for Colleges and Universities Nationwide 2Health News:Adapt Courseware Releases Introduction to Sociology for Colleges and Universities Nationwide 3Health News:Lyrica Discount Cards Now Available From MedicationDiscountCard.com 2Health News:2013 NBA Draft Tickets: Cheap Concert Tickets Announces that Official Onsales for the 2013 NBA Draft Begin at 10:00 am Local Time on Wednesday, May 22, 2013 2Health News:Westchester Dermatologist Abadir Associates Offers New Neck Lift Surgery Alternative 2
... , ... Movement, a new coalition under the leadership of Matthias Rath, MD, is spearheading an online ... and defend the rights of Americans to access safe, science-based, natural health alternatives. , ... Santa Clara, CA (PRWEB) June 29, ...
... , ... According to the US Drug Watchdog, "we want to hear ... lost their sense of smell." The group says, "on June 16, 2009, ... marketed over-the-counter as cold remedies because they are associated with the loss ...
... ... for Asia Adult Expo (AAE) for the second consecutive year. , ... Macau (PRWEB) June 28, 2009 -- Macau.com, the leading ... agency for Asia Adult Expo (AAE) for the second consecutive year., , , , ...
... incontinence and more can result, research shows , SUNDAY, ... problem, it turns out, is associated with potentially significant ... of the scientific evidence, researchers found that constipation might ... complications such as hemorrhoids, anal fissures, fecal incontinence, colonic ...
... AcademyHealth announced its 2009 award winners today, recognizing leading ... contributions for the fields of health services research and ... by distinguished leaders from our field, honor new and ... improve health and health care," said W. David Helms, ...
... sports injury , SATURDAY, June 27 (HealthDay News) -- If ... your chance of getting hurt during your pursuit of recreation. ... injury, the rates could be reduced significantly if athletes took ... Dr. Victor Khabie, chief of orthopedic surgery and sports medicine ...
Cached Medicine News:Health News:Americans' Right to Access Natural Health Alternatives in Peril, Says Natural Health Freedom Movement 2Health News:Americans' Right to Access Natural Health Alternatives in Peril, Says Natural Health Freedom Movement 3Health News:Americans' Right to Access Natural Health Alternatives in Peril, Says Natural Health Freedom Movement 4Health News:Americans' Right to Access Natural Health Alternatives in Peril, Says Natural Health Freedom Movement 5Health News:The US Drug Watchdog Expands its Zicam Investigation and Wants to Hear From All Users Who Lost Their Sense of Smell 2Health News:Macau.com Partners With Asia Adult Expo As Official Travel Company 2Health News:Macau.com Partners With Asia Adult Expo As Official Travel Company 3Health News:Constipation May Lead to Other Problems 2Health News:Constipation May Lead to Other Problems 3Health News:AcademyHealth honors leading health services researchers 2
... ESR-10 Manual Rack is a manual ... the erythrocyte sedimentation rate (ESR) of ... 1.2ml Streck ESR-Vacuum Tubes. The rack ... simultaneously. The ESR-10 Manual Rack exhibits ...
... Cytometry Concentrate is for use as a ... cytometry. Each 70ml bottle of Cytometry Concentrate ... distilled water. Compared to Cubitainers, Streck Cytometry ... and saves money without compromising performance. Streck ...
... a stabilized preparation of human ... used as a complete process ... cells. It is compatible with ... strategies. CD-Chex CD34 has 30-day ...
... reagent manufactured for the ... hemoglobin and white blood ... is manufactured specifically for ... CELL-DYN® 1700. The shelf ...
Medicine Products: